Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$4.12 +0.05 (+1.23%)
At close: Oct 2, 2026 · 4:00 PM EDT

Recursion Pharmaceuticals (RXRX) Property, Plant & Equipment (Net) (2020 - 2026)

Updated

Recursion Pharmaceuticals' Property, Plant & Equipment (Net) was $89.62 million in Q2 2026, down 25.3% from $120.04 million a year earlier and down 6.5% from the prior quarter.

Analysis

Recursion Pharmaceuticals (RXRX) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends

At the end of FY2025, Property, Plant & Equipment (Net) at Recursion Pharmaceuticals came in at $103.93 million, down 26.3% from FY2024.

  • Property, Plant & Equipment (Net) shows a five-year compound annual growth rate of 32.0% (FY2020 to FY2025).
  • In earlier years, Property, Plant & Equipment (Net) was $141.06 million in FY2024 (+63.1%), $86.51 million in FY2023 (-1.9%), $88.19 million in FY2022 (+36.3%) and $64.73 million in FY2021 (+149.3%).
  • The Q2 2026 figure marks the lowest quarterly Property, Plant & Equipment (Net) since Q3 2024.
  • Compared with a year earlier, Property, Plant & Equipment (Net) has declined for three straight quarters, with growth averaging 13.4% over the last eight quarters.
  • The best year-over-year quarter for Property, Plant & Equipment (Net) over five years was Q4 2021 (growth of 149.3%); the worst was Q4 2025 (a decline of 26.3%).
  • Per Business Quant data, RXRX's Property, Plant & Equipment (Net) in the three quarters before Q2 2026 was $95.81 million (Q1 2026), $103.93 million (Q4 2025) and $111.71 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 29.29 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 23.58 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 5.80 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 25.74 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 10.69 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 13.62 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 8.55 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 5.83 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 19.03 Bn
10 Recursion Pharmaceuticals 2.20 Bn -402.71 Mn -3.82 Mn 89.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 89.62 Mn
Mar 31, 2026 95.81 Mn
Dec 31, 2025 103.93 Mn
Sep 30, 2025 111.71 Mn
Jun 30, 2025 120.04 Mn
Mar 31, 2025 126.83 Mn
Dec 31, 2024 141.06 Mn
Sep 30, 2024 84.41 Mn
Jun 30, 2024 83.63 Mn
Mar 31, 2024 86.72 Mn
Dec 31, 2023 86.51 Mn
Sep 30, 2023 86.25 Mn
Jun 30, 2023 89.77 Mn
Mar 31, 2023 90.00 Mn
Dec 31, 2022 88.19 Mn
Sep 30, 2022 85.78 Mn
Jun 30, 2022 81.51 Mn
Mar 31, 2022 70.70 Mn
Dec 31, 2021 64.73 Mn
Sep 30, 2021 55.44 Mn
API Access

Recursion Pharmaceuticals Property, Plant & Equipment (Net) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=RXRX&period=max&api_key=YOUR_API_KEY